Senior insider sale
EVP and CFO at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$1.65M
3.30K shares
What this filing means
WAGNER CHARLES F JR plans to sell 3.30K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $1.65M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/10/2025ACC: 0001959173-25-001870
Officer· EVP and CFO
Since Apr 2019
3.30K
Shares to sell
$1.65M
Approx. market value
3.30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months8
ESPP Purchase
Cash
11/14/2021
22.00ESPP Purchase
Cash
5/14/2021
76.00Restricted Stock Vesting
Compensation
4/30/2021
342.00Restricted Stock Vesting
Compensation
2/24/2021
342.00Restricted Stock Vesting
Compensation
2/10/2021
2.26KESPP Purchase
Cash
11/13/2020
61.00ESPP Purchase
Cash
5/14/2020
99.00ESPP Purchase
Cash
11/14/2019
98.00Total acquired3.30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/14/2021 | ESPP Purchase Cash | 22.00 | — |
5/14/2021 | ESPP Purchase Cash | 76.00 | — |
4/30/2021 | Restricted Stock Vesting Compensation | 342.00 | — |
2/24/2021 | Restricted Stock Vesting Compensation | 342.00 | — |
2/10/2021 | Restricted Stock Vesting Compensation | 2.26K | — |
11/13/2020 | ESPP Purchase Cash | 61.00 | — |
5/14/2020 | ESPP Purchase Cash | 99.00 | — |
11/14/2019 | ESPP Purchase Cash | 98.00 | — |
| Total | 3.30K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.30K
Market value
$1.65M
3/10/2025
Total
Units
3.30K
Value
$1.65M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/10/2025 | 3.30K | $1.65M | NASDAQ | Planned |
| Total | 3.30K | $1.65M | ||